Ozempic Lawsuit – Wegovy Rybelsus Lawsuits – Stomach Injury Settlements
Have you or a loved one suffered from gastroparesis or stomach paralysis after using the weight loss drugs Ozempic, Wegovy, or Rybelsus?
You may be entitled to compensation. These medications, intended for type 2 diabetes and obesity treatment, have been linked to serious gastrointestinal complications.
Criteria for Consideration:
- Age: 75 or younger at the time of intake
- Brand Name Use: Ozempic, Wegovy, or Rybelsus only (no generics or other GLP-1 RA drugs)
- Diagnosis: Gastroparesis, Stomach Paralysis, or Gastric Obstruction while on the drug or within 30 days of stopping
Understanding the Lawsuits
Recent reports and studies have highlighted the risks associated with these GLP-1 receptor agonists. Doctors are reporting cases of gastroparesis/stomach paralysis linked to these weight loss drugs, yet the manufacturer, Novo Nordisk, did not adequately warn patients and healthcare providers.
Understanding Ozempic, Wegovy, and Rybelsus
- These drugs are glucagon-like peptide-1 receptor agonists (GLP-1 RA) containing the active ingredient semaglutide.
- Ozempic is for type 2 diabetes treatment, while Wegovy is FDA-approved for weight loss.
- Rybelsus is an oral tablet for type 2 diabetes.
About Gastroparesis/Stomach Paralysis
This condition affects stomach emptying, leading to nausea, vomiting, and more. There is no cure, and treatments provide temporary relief.
Complications & Risks
- Dehydration
- Malnutrition
- Blood sugar control issues
- Decreased quality of life
- Life-threatening bezoars (solid masses in the stomach)
Compensation You Deserve
In a verdict or settlement, you may be eligible for various types of compensation, including:
- Medical treatment costs (past and future)
- Lost income (past and future)
- Pain and suffering
- Loss of enjoyment of life
- Possible punitive damages
Contact Us Today:
If you or someone you know has suffered due to GLP-1 receptor agonist complications, don’t hesitate to reach out. Call us at (251) 200-5382
